Chymopapain and method of purifying it on an inhibitory dipeptide affinity column
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 10, 1995
Grant Date -
N/A
app pub date -
Dec 13, 1991
filing date -
Apr 28, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of purifying chymopapain by active site directed affinity chromatography using inhibitory dipeptides as affinity ligands is presented. The inhibitory dipeptides have C-terminal aldehyde derivatives of phenylalanine selected from the group consisting of the semicarbazone, the methoxyimine and the oxime. The purified chymopapain has a specific activity against BAPNA (1 mM) at 40.degree. C. and pH 6.8 of between 3000 and 4500 units per mg and contains less than 0.2% each of papaya proteinase III (PPIII), papain and papaya proteinase IV (PPIV). The use of purified chymopapain in pharmaceutical compositions for the treatment of damaged mammalian spinal discs is also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully